KNSA logo

Kiniksa Pharmaceuticals (KNSA) Current Assets

Annual Current Assets

$331.80 M
+$55.50 M+20.09%

December 31, 2024


Summary


Performance

KNSA Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAbalance sheetmetrics:

Quarterly Current Assets

$331.80 M
+$20.50 M+6.58%

December 31, 2024


Summary


Performance

KNSA Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

KNSA Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.1%0.0%
3 y3 years+68.9%+68.9%
5 y5 years+37.3%+37.3%

KNSA Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+68.9%at high+84.4%
5 y5-year-0.4%+68.9%-12.3%+84.4%
alltimeall time-0.4%+604.4%-12.3%+604.4%

Kiniksa Pharmaceuticals Current Assets History

DateAnnualQuarterly
Dec 2024
$248.75 M(-0.5%)
$331.80 M(+6.6%)
Sep 2024
-
$311.30 M(+3.4%)
Jun 2024
-
$301.02 M(+11.2%)
Mar 2024
-
$270.59 M(-2.1%)
Dec 2023
$250.03 M(+15.4%)
$276.30 M(+7.9%)
Sep 2023
-
$256.11 M(+4.1%)
Jun 2023
-
$246.04 M(+6.3%)
Mar 2023
-
$231.50 M(-4.8%)
Dec 2022
$216.61 M(+495.8%)
$243.06 M(+0.5%)
Sep 2022
-
$241.81 M(+34.4%)
Jun 2022
-
$179.94 M(-9.5%)
Mar 2022
-
$198.76 M(+1.2%)
Dec 2021
$36.35 M
$196.45 M(-9.7%)
Sep 2021
-
$217.51 M(-11.2%)
Jun 2021
-
$244.81 M(-11.2%)
DateAnnualQuarterly
Mar 2021
-
$275.56 M(-17.3%)
Dec 2020
$16.21 M(+25.6%)
$333.25 M(-11.9%)
Sep 2020
-
$378.41 M(+43.1%)
Jun 2020
-
$264.49 M(+24.1%)
Mar 2020
-
$213.06 M(-11.8%)
Dec 2019
$12.91 M(+57.1%)
$241.63 M(-10.0%)
Sep 2019
-
$268.34 M(-9.5%)
Jun 2019
-
$296.46 M(-11.5%)
Mar 2019
-
$334.96 M(+6.8%)
Dec 2018
$8.21 M(+2017.3%)
$313.75 M(-8.1%)
Sep 2018
-
$341.53 M(-6.1%)
Jun 2018
-
$363.87 M(+63.6%)
Mar 2018
-
$222.45 M(+372.3%)
Dec 2017
$388.00 K(+191.7%)
$47.10 M
Dec 2016
$133.00 K
-

FAQ

  • What is Kiniksa Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual current assets year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly current assets year-on-year change?

What is Kiniksa Pharmaceuticals annual total current assets?

The current annual current assets of KNSA is $331.80 M

What is the all time high annual current assets for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual total current assets is $333.25 M

What is Kiniksa Pharmaceuticals annual current assets year-on-year change?

Over the past year, KNSA annual total current assets has changed by +$55.50 M (+20.09%)

What is Kiniksa Pharmaceuticals quarterly total current assets?

The current quarterly current assets of KNSA is $331.80 M

What is the all time high quarterly current assets for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly total current assets is $378.41 M

What is Kiniksa Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, KNSA quarterly total current assets has changed by $0.00 (0.00%)